Description
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
| Product Unit Size | Cost | Quantity | Stock |
|---|
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
| Purity | ≥95% |
|---|---|
| Formula | C18H25N5O5S |
| Formula Wt. | 423.4 |
| Synonym | MGP-pNa |
| Solubility | Soluble in water. |
| Appearance | White to off white powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
McCarty MF, DiNicolantonio JJ. The molecular biology and pathophysiology of vascular calcification. Postgrad Med. 2014 Mar;126(2):54-64. PMID: 24685968.
Schurgers LJ, Uitto J, Reutelingsperger CP. Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization. Trends Mol Med. 2013 Apr;19(4):217-26. PMID: 23375872.
Synthetic antioxidant that induces phase II enz...
Synthetic analog of 1,4-naphthoquinone, precurs...
Metabolite of spironolactone; Na+/K+ ATPase par...
Anthracenedione, DNA intercalator; Pim-1 inhibi...
Endogenous peptide hormone, involved in enteric...
Cysteine-ITC conjugate, antioxidant; HDAC inhib...
STING agonist
Tretraeptide, binds cell surface integrins.
5-Fluorouracil prodrug, pyrimidine nucleoside a...
Purine derivative; CDK inhibitor.
Neuropeptide hormone found in insects, involved...
Selective CDK2 inhibitor.
Inhibitor of Bcl-2 and Bcl-xL
NSAID; COX-1/2 and PDE inhibitor.
MGMT inhibitor.
Cell-penetrating peptide, carries large conjuga...
Pneumonia antigen
Aminopeptidase inhibitor.
EGFR, VEGFR inhibitor.
GABA-A agonist, NMDA antagonist, voltage-gated ...